SCP2D1, or Sterol Carrier Protein 2 Domain Containing 1, is a protein that has not been extensively characterized in scientific literature, and as such, there is limited information available on its specific function and role within cellular biology. The SCP2D1 designation may not correspond to a widely recognized protein name in scientific databases or publications, and it could be a less-studied protein whose details have yet to be elucidated.
When proteins are not well-characterized, their names often derive from predicted domains, homologies, or structural features inferred from gene sequencing data. For instance, the "SCP2" portion of the name suggests a potential relationship to Sterol Carrier Protein 2, which is involved in lipid transfer and metabolism, although this is speculative without direct evidence. The "Domain Containing 1" part implies that this protein might contain a specific domain, similar to one found in Sterol Carrier Protein 2, which might mediate a particular function or interaction with other molecules.In general, proteins that carry the SCP2 domain are implicated in the intracellular transport of lipids, which is crucial for various metabolic processes, including lipid synthesis, breakdown, and conversion into other biologically active molecules. These proteins can participate in maintaining cellular lipid homeostasis, contributing to the proper function of membranes and the production of signaling molecules.
VOIR ÉGALEMENT...
Items 1 to 10 of 11 total
Afficher:
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Active l'adénylyl cyclase, augmentant les niveaux d'AMPc, ce qui peut moduler les voies du métabolisme des lipides, influençant potentiellement SCP2D1. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
La lovastatine, un inhibiteur de l'HMG-CoA réductase, affecte la synthèse du cholestérol, ce qui pourrait avoir un impact sur les voies liées au SCP2D1. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
En tant qu'agoniste PPARα, le fénofibrate module le métabolisme des lipides, ce qui pourrait indirectement affecter SCP2D1. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
La rosiglitazone, un agoniste PPARγ, influence le métabolisme des lipides et pourrait avoir un impact indirect sur SCP2D1. | ||||||
Cholic acid | 81-25-4 | sc-255020 sc-255020A sc-255020B sc-255020C sc-255020D | 25 g 100 g 500 g 1 kg 5 kg | $48.00 $121.00 $567.00 $998.00 $4480.00 | 11 | |
Acide biliaire primaire, l'acide cholique est impliqué dans la digestion et l'absorption des lipides, affectant potentiellement le SCP2D1. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $65.00 $262.00 | 2 | |
Un autre agoniste PPARα, le gemfibrozil, module le métabolisme des lipides, influençant potentiellement le SCP2D1. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $61.00 $122.00 | 1 | |
Influence le métabolisme des lipides, avec un impact potentiel sur les voies liées au SCP2D1. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Comme la lovastatine, la simvastatine, en tant qu'inhibiteur de l'HMG-CoA réductase, pourrait affecter le SCP2D1. | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $51.00 | 7 | |
Inhibe la lipase, ce qui a un impact sur la digestion et l'absorption des lipides, influençant potentiellement SCP2D1. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $94.00 $236.00 | 12 | |
Inhibe l'absorption du cholestérol, ce qui pourrait avoir un impact sur les voies liées au SCP2D1. | ||||||